-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WQWh/Y1Y2so5piHwU1B2QvTPJiqicxh2ddOAHeZwpOvBLYcnhiFh1m/WQbS2sRJi N56RTNYQ24DBDYaEix4oug== 0001019687-08-005623.txt : 20081224 0001019687-08-005623.hdr.sgml : 20081224 20081224125306 ACCESSION NUMBER: 0001019687-08-005623 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20081224 DATE AS OF CHANGE: 20081224 GROUP MEMBERS: CASSIOPEA SA GROUP MEMBERS: COSMO HOLDING S.P.A. GROUP MEMBERS: COSMO PHARMACEUTICALS S.P.A GROUP MEMBERS: GUISEPPE CIPRIANO GROUP MEMBERS: LUIGI MORO GROUP MEMBERS: MAURO AJANI SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SANTARUS INC CENTRAL INDEX KEY: 0001172480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330734433 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79925 FILM NUMBER: 081269834 BUSINESS ADDRESS: STREET 1: 3721 VALLEY CENTRE DRIVE STREET 2: STE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8583145700 MAIL ADDRESS: STREET 1: 3721 VALLEY CENTRE DRIVE STREET 2: STE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Cosmo Technologies, Ltd. CENTRAL INDEX KEY: 0001452697 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 42-43 AMIENS ST. CITY: DUBLIN STATE: L2 ZIP: 1 BUSINESS PHONE: 353-1-81-70370 MAIL ADDRESS: STREET 1: 42-43 AMIENS ST. CITY: DUBLIN STATE: L2 ZIP: 1 SC 13G 1 cosmo_13g-121508.htm SCHEDULE 13G cosmo_13g-121508.htm
OMB APPROVAL
OMB Number: 3235-0145
Expires: February 28, 2009
Estimated average burden
hours per response . . . 10.4
 
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. ___)*

SANTARUS, INC.
(Name of Issuer)
 
common stock, par value $0.0001 per share
(Title of Class of Securities)
 
 
802817304
 
(CUSIP Number)
 
December 15, 2008
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[_]
Rule 13d-1(b)
 
[X]
Rule 13d-1(c)
 
[_]
Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
SEC 1745 (3-06)
 

 
 
     CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Cosmo Technologies Limited
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Ireland
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        CO


Page 2 of 12 pages
 
 
 

 

CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Cosmo Pharmaceuticals S.p.A.
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Italy
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        CO

Page 3  of 12 pages
 
 
 

 

CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Cosmo Holding S.p.A.
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Italy
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        CO

Page 4 of 12 pages
 
 

 

CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Cassiopea SA
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Luxembourg
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        CO

Page 4 of 12 pages
 
 

 

CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Giuseppe Cipriano
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Italy
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        IN

Page 6 of 12 pages
 
 

 

CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Luigi Moro
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Italy
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        IN

Page 7 of 12 pages
 
 

 

CUSIP No. 802817304
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
                                Mauro Ajani
2.            Check the Appropriate Box if a Member of a Group (See Instructions)
                    (a)  [   ]
                    (b)  [   ]
3.           SEC Use Only
 
4.           Citizenship or Place of Organization
Italy
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.          Sole Voting Power
   
 
6.          Shared Voting Power
 
6,000,000
 
 
7.          Sole Dispositive Power
   
 
8.          Shared Dispositive Power
 
6,000,000
 
9.           Aggregate Amount Beneficially Owned by Each Reporting Person
6,000,000
 
10.           Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [   ]
 
11.           Percent of Class Represented by Amount in Row (9)
10.4%
 
12.           Type of Reporting Person (See Instructions)
                        IN

Page 8 of 12 pages
 
 

 


Item 1.
 
(a)
Name of Issuer :
SANTARUS, INC.
 
 
(b)
Address of Issuer’s Principal Executive Offices:
3721 Valley Centre Drive, Suite 400, San Diego, CA 92130
Item 2.
 
(a) & (c)
Name & Citizenship of Person Filing:
(i)  Cosmo Technologies Limited, an Irish corporation (“Cosmo”)
(ii)  Cosmo Pharmaceuticals S.p.A., an Italian corporation (“Cosmo Parent”)
(iii)  Cosmo Holding S.p.A., an Italian corporation (“Cosmo Holding”)
(iv)  Cassiopea SA, a Luxembourg corporation (“Cassiopea”)
(v)  Giuseppe Cipriano, an Italian citizen
(vi)  Luigi Moro, an Italian citizen
(vii) Mauro Ajani, an Italian citizen
 
 
(b)
Address of Principal Business Office or, if none, Residence:
The address for Cosmo is 42-43 Amiens Street, Dublin 1, Ireland.  The address for Cosmo Parent and Messrs Ajani, Cipriano and Moro is Via C. Colombo, 1, 20020 Lainate-Milano, Italy.  The address for Cosmo Holding is Piazza della Repubblica, 3 20121 Milano, Italy.  The address for Cassiopea is 31, Boulevard Grand-Duchesse Charlotte L-1331 Luxembourg.
 
(d)
Title of Class of Securities:
common stock, par value $0.0001 per share
 
 
(e)
CUSIP Number:
802817304
 
     
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
(a)
[  ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
 
(b)
[  ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
(c)
[  ]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
 
(d)
[  ]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
 
(e)
[  ]
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
 
(f)
[  ]
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
(g)
[  ]
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
 
 

Page 9 of 12 pages
 
 

 
 
 
 
 
(h)
[   ]
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i)
[  ]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
(j)
[  ]
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 
If this statement is filed pursuant to Rule 13d-1(c), check this box: [ X ]
 
Item 4.
  Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
(a)
Amount beneficially owned: 6,000,000 *
 
(b)
Percent of class:   10.4%. **
 
(c)
Number of shares as to which the person has:
   
(i)
Sole power to vote or to direct the vote
 
   
(ii)
Shared power to vote or to direct the vote
6,000,000
   
(iii)
Sole power to dispose or to direct the disposition of
 
   
(iv)
Shared power to dispose or to direct the disposition of
6,000,000
 
*  All shares are being reported for Cosmo, Cosmo Parent, Cosmo Holding, Cassiopea, Giuseppe Cipriano, Luigi Moro, and Mauro Ajani, who may be considered beneficial owners of the 6,000,000 shares.  The shares are directly held by Cosmo, which is the wholly-owned subsidiary of Cosmo Parent, which is the majority-owned subsidiary of Cosmo Holding, which is the majority-owned subsidiary of Cassiopea.  Therefore, Cosmo Parent, Cosmo Holding and Cassiopea may be deemed the beneficial owner of the 6,000,000 shares.  Giuseppe Cipriano and Luigi Moro may be deemed the beneficial owner of the 6,000,000 shares because they are the only two directors of Cosmo.  Mauro Ajani may be deemed the beneficial owner of the 6,000,000 shares because he is the majority shareholder of Cassiopea.

**  The percent of class computations are based on 51,528,113 shares of common stock outstanding, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 3, 2008.

Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d3(d)(1).
 
Item 5.  Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ].
 

Page 10  of 12 pages
 
 

 

Item 6.    Ownership of More than Five Percent on Behalf of Another Person.
 
Not Applicable
 
  Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
 
Not Applicable
 
Item 8.     Identification and Classification of Members of the Group
 
Not Applicable
 
Item 9.    Notice of Dissolution of Group
 
Not Applicable
 
Item 10. Certification
 
(b)           The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
Exhibit  No.                                           Exhibit Description
---------------------------------------------------------------------------------------------------------------------------------------
 
99.1
Joint Filing Agreement dated December 22, 2008, by and among Cosmo Technologies Limited, Cosmo Pharmaceuticals S.p.A., Cosmo Holding S.p.A., Cassiopea SA, Giuseppe Cipriano, Luigi Moro and Mauro Ajani
 
[The remainder of this page intentionally left blank.]
 

Page 11 of 12 pages
 
 

 

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
COSMO TECHNOLOGIES LIMITED
 
December 22, 2008                                                                
Date
 
       /s/ Giuseppe Cipriano                         
Signature
   Giuseppe Cipriano - Director                  
Name/TitleName/Title
 
COSMO PHARMACEUTICALS S.p.A.
 
December 22, 2008                                                                
Date
 
   /s/ Mauro Ajani                                       
Signature
   Mauro Ajani – Managing Director          
Name/TitleName/Title
 
COSMO HOLDING S.p.A.
 
December 22, 2008                                                                
Date
 
    /s/ Giuseppe Cipriano                           
Signature
 
    Giuseppe Cipriano - Chairman            
Name/TitleName/Title
 
CASSIOPEA SA
 
December 22, 2008                                                                
Date
 
       /s/ Sonja Bemtgen                              
Signature
 
   Sonja Bemtgen  - Director                     
Name/TitleName/Title
 
December 22, 2008                                                                
Date
 
     /s/ Giuseppe Cipriano                           
Signature
 
Giuseppe Cipriano, an individual                                                                
Name/TitleName/Title
 
December 22, 2008                                                                
Date
 
  /s/ Luigi Moro                                        
Signature
 
Luigi Moro, an individual                                                                
Name/Title
December 22, 2008                                                                
Date
 
    /s/ Mauro Ajani                                    
Signature
 
Mauro Ajani, an individual                                                                
Name/Title
 

 
 
 
Page 12 of 12 pages
EX-99.1 2 cosmo_13g-ex9901.htm JOINT FILING AGREEMENT cosmo_13g-ex9901.htm
Exhibit 99.1
 
 
JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, on behalf of the Reporting Persons (as defined in the joint filing), of a statement on Schedule 13G (including amendments thereto) with respect to the common stock of Santarus, Inc., and that this agreement be included as a Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such statement on Schedule 13G (including any and all amendments thereto), and for the accuracy and completeness of the information concerning such party contained therein.  However, no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This agreement may be executed in any number of counterparts, all of which taken together shall constitute the same instrument.

[THE NEXT PAGE IS THE SIGNATURE PAGE]
[THE REMAINDER OF THIS PAGE IS INTENTIONALLY BLANK]
 
 
 
 
 

 



IN WITNESS WHEREOF, the parties hereto have executed this agreement as of this 22nd day of December, 2008.


 
Cosmo Technologies Limited
 
 
Cosmo Pharmaceuticals S.p.A.           
 
 
Date: _____________   Date: _____________  
/s/ Giuseppe Cipriano   /s/ Mauro Ajani             
Signature   Signature  
 
Giuseppe Cipriano - Director                
 
 
Mauro Ajani – Managing  Director    
 
Name/Title   Name/Title  
       
Cassiopea SA
 
 
Cosmo Holding S.p.A.
 
 
Date: _____________
 
 
Date: _____________
 
 
/s/ Sonja Bemtgen   /s/ Giuseppe Cipriano  
Signature   Signature  
 
Sonja Bemtgen - Director
 
 
Giuseppe Cipriano - Chairman   
 
Name/Title   Name/Title  
       
Date: _____________
 
 
Date: _____________
 
 
/s/ Luigi Moro     /s/ Mauro Ajani    
Signature   Signature  
 
Luigi Moro           
 
 
Mauro Ajani           
 
Name/Title   Name/Title  
       
Date: _____________
 
     
/s/ Giuseppe Cipriano        
Signature 
 
     
Giuseppe Cipriano       
Name/Title 
     

 

 
-----END PRIVACY-ENHANCED MESSAGE-----